118 related articles for article (PubMed ID: 26048120)
1. [Not Available].
Wolf E; Rüsenberg R
MMW Fortschr Med; 2015 Jun; 157 Suppl 2():42-5. PubMed ID: 26048120
[No Abstract] [Full Text] [Related]
2. [Not Available].
Stingl W
MMW Fortschr Med; 2015 Jun; 157 Suppl 2():55. PubMed ID: 26048126
[No Abstract] [Full Text] [Related]
3. [Declining costs].
Neumaier J
MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259908
[No Abstract] [Full Text] [Related]
4. Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection.
Saab S; Gordon SC; Park H; Sulkowski M; Ahmed A; Younossi Z
Aliment Pharmacol Ther; 2014 Sep; 40(6):657-75. PubMed ID: 25065960
[TBL] [Abstract][Full Text] [Related]
5. [HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?].
MMW Fortschr Med; 2014 Jun; 156 Suppl 1():62-3. PubMed ID: 25026863
[No Abstract] [Full Text] [Related]
6. Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial.
Stahmeyer JT; Krauth C; Bert F; Pfeiffer-Vornkahl H; Alshuth U; Hüppe D; Mauss S; Rossol S
J Viral Hepat; 2016 Feb; 23(2):105-15. PubMed ID: 26411532
[TBL] [Abstract][Full Text] [Related]
7. [Does combination therapy of chronic viral hepatitis C with interferon-alpha and ribavirin approach financial limits?].
Steimann RU; Bode JC
Versicherungsmedizin; 2000 Mar; 52(1):24-7. PubMed ID: 10718088
[TBL] [Abstract][Full Text] [Related]
8. Cost of treating hepatitis C in Germany: a retrospective multicenter analysis.
Stahmeyer JT; Rossol S; Bert F; Antoni C; Demir M; Hinrichsen H; Hüppe D; Teuber G; Wiebner B; Wedemeyer H; Krauth C
Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1278-85. PubMed ID: 25144493
[TBL] [Abstract][Full Text] [Related]
9. [Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012].
Blasco AJ; Arribas JR; Boix V; Clotet B; Domingo P; González-García J; Knobel H; López JC; Llibre JM; Lozano F; Miró JM; Podzamczer D; Santamaría JM; Tuset M; Zamora L; Lázaro P; Gatell JM;
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):283-93. PubMed ID: 22525829
[TBL] [Abstract][Full Text] [Related]
10. Cost of antiretroviral treatment for HIV patients in two centres of North India.
Sharma A; Prinja S; Sharma A; Gupta A; Arora SK
Int J STD AIDS; 2019 Jul; 30(8):769-778. PubMed ID: 31081489
[No Abstract] [Full Text] [Related]
11. Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.
Gellad ZF; Reed SD; Muir AJ
Antivir Ther; 2012; 17(6 Pt B):1189-99. PubMed ID: 23186646
[TBL] [Abstract][Full Text] [Related]
12. [The cost of an HIV patient. Lack of funds for optimal treatment?].
Stoll M; Schulte E; Claes C; Graf von der Schulenburg JM; Schmidt RE
MMW Fortschr Med; 2001 Apr; 143 Suppl 1():72-7. PubMed ID: 11373789
[TBL] [Abstract][Full Text] [Related]
13. Special report: cost-effectiveness studies of new hepatitis C treatments.
Mark DH;
Technol Eval Cent Assess Program Exec Summ; 2015 Jan; 29(10):1-3. PubMed ID: 25962188
[No Abstract] [Full Text] [Related]
14. [Costs of a guideline-based treatment of patients with chronic hepatitis C in the era of interferon-free treatment].
Stahmeyer JT; Rossol S; Bert F; Liersch S; Krauth C
Z Gastroenterol; 2016 Aug; 54(8):760-9. PubMed ID: 27529526
[TBL] [Abstract][Full Text] [Related]
15. Costs of eliminating HIV in South Africa have been underestimated.
Wagner B; Blower S
Lancet; 2010 Sep; 376(9745):953-4. PubMed ID: 20851250
[No Abstract] [Full Text] [Related]
16. [Costs of a guideline-based treatment of patients with chronic hepatitis C in Germany].
Stahmeyer JT; Rossol S; Bert F; Abdelfattah M; Krauth C
Z Gastroenterol; 2014 Sep; 52(9):1041-9. PubMed ID: 25075995
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of strategy-based approach to treatment of genotype 1 chronic hepatitis C.
Zhao YJ; Khoo AL; Lin L; Teng M; Koh CJ; Lim SG; Lim BP; Dan YY
J Gastroenterol Hepatol; 2016 Sep; 31(9):1628-37. PubMed ID: 26990023
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
[TBL] [Abstract][Full Text] [Related]
19. Medical resource utilisation and healthcare costs in patients with chronic hepatitis C viral infection and thrombocytopenia.
Poordad F; Theodore D; Sullivan J; Grotzinger K
J Med Econ; 2011; 14(2):194-206. PubMed ID: 21348807
[TBL] [Abstract][Full Text] [Related]
20. [Naturopathy consultation. Soon all patients will be curable. Decisive breakthrough in therapy of hepatitis C ].
Einecke D
MMW Fortschr Med; 2014 Feb; 156(3):26-7. PubMed ID: 24938054
[No Abstract] [Full Text] [Related]
[Next] [New Search]